NCT01266083 2024-11-19WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)Sellas Life Sciences GroupPhase 2 Completed22 enrolled 8 charts
NCT01265433 2024-10-09Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality TherapySellas Life Sciences GroupPhase 2 Completed41 enrolled 12 charts